日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications

中东九个国家新诊断的晚期卵巢癌中同源重组缺陷的患病率、真实世界检测途径及治疗意义

Shash, Emad; Vardar, Mehemet Ali; Taskiran, Cagatay; Boujassoum, Salha; Riromar, Jamila; Aboutaleb, Ahmed; Sadek, Farah; Samy, Eman; Bahaj, Waleed

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study

转移性尿路上皮癌患者免疫检查点抑制剂疗效相关的临床变量:一项多中心回顾性队列研究

Labidi, Soumaya; Meti, Nicholas; Barua, Reeta; Li, Mengqi; Riromar, Jamila; Jiang, Di Maria; Fallah-Rad, Nazanin; Sridhar, Srikala S; Del Rincon, Sonia V; Pezo, Rossanna C; Ferrario, Cristiano; Cheng, Susanna; Sacher, Adrian G; Rose, April A N

The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy

骨转移对接受一线铂类化疗的转移性尿路上皮癌患者预后的影响

Alqaisi, Husam A; Stecca, Carlos; Veitch, Zachary W; Riromar, Jamila; Kaiser, Jeenan; Fallah-Rad, Nazanin; Jiang, Di Maria; North, Scott; Samnani, Sunil; Alimohamed, Nimira; Sridhar, Srikala S